Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Grant | $50,000 | 2 | 98.2% |
| Food and Beverage | $802.28 | 40 | 1.6% |
| Travel and Lodging | $102.61 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $50,145 | 5 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $283.59 | 13 | $0 (2024) |
| Valeant Pharmaceuticals North America LLC | $186.70 | 8 | $0 (2017) |
| ABBVIE INC. | $106.09 | 5 | $0 (2024) |
| Janssen Biotech, Inc. | $102.80 | 6 | $0 (2022) |
| Gilead Sciences, Inc. | $39.86 | 3 | $0 (2018) |
| Intercept Pharmaceuticals, Inc. | $28.33 | 2 | $0 (2018) |
| Merck Sharp & Dohme Corporation | $12.17 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $116.64 | 5 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($68.95) |
| 2023 | $215.55 | 6 | Boston Scientific Corporation ($145.35) |
| 2022 | $78.97 | 3 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($51.52) |
| 2021 | $100.66 | 5 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($100.66) |
| 2019 | $50,021 | 3 | Boston Scientific Corporation ($50,000) |
| 2018 | $70.18 | 5 | Intercept Pharmaceuticals, Inc. ($28.33) |
| 2017 | $302.24 | 16 | Valeant Pharmaceuticals North America LLC ($186.70) |
All Payment Transactions
43 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/13/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $24.26 | General |
| Category: Gastroenterology | ||||||
| 10/16/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $22.14 | General |
| Category: Gastroenterology | ||||||
| 10/01/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $22.46 | General |
| Category: IMMUNOLOGY | ||||||
| 09/30/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $22.55 | General |
| Category: Gastroenterology | ||||||
| 04/11/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $25.23 | General |
| Category: IMMUNOLOGY | ||||||
| 12/07/2023 | Boston Scientific Corporation | ORISE (Device) | Food and Beverage | In-kind items and services | $23.20 | General |
| Category: ORISE_ENDO | ||||||
| 12/01/2023 | Boston Scientific Corporation | — | Travel and Lodging | In-kind items and services | $102.61 | General |
| Category: General - Therapies_ENDO | ||||||
| 12/01/2023 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $19.54 | General |
| Category: General - Therapies_ENDO | ||||||
| 11/01/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $24.55 | General |
| Category: Gastroenterology | ||||||
| 09/20/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $21.96 | General |
| Category: Gastroenterology | ||||||
| 03/30/2023 | AbbVie Inc. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $23.69 | General |
| Category: IMMUNOLOGY | ||||||
| 11/02/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $23.77 | General |
| Category: Gastroenterology | ||||||
| 10/13/2022 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $27.45 | General |
| Category: Immunology | ||||||
| 03/04/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $27.75 | General |
| Category: Gastroenterology | ||||||
| 12/23/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $24.77 | General |
| Category: Gastroenterology | ||||||
| 12/15/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.13 | General |
| Category: Gastroenterology | ||||||
| 11/12/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $24.12 | General |
| Category: Gastroenterology | ||||||
| 07/14/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $20.58 | General |
| Category: Gastroenterology | ||||||
| 03/08/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $12.06 | General |
| Category: Gastroenterology | ||||||
| 12/13/2019 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $20.65 | General |
| Category: Immunology | ||||||
| 07/24/2019 | Boston Scientific Corporation | GENERAL BILIARY DEVICES (Device) | Grant | Cash or cash equivalent | $25,000.00 | General |
| Category: BILIARY DEVICES | ||||||
| 01/23/2019 | Boston Scientific Corporation | GENERAL BILIARY DEVICES (Device) | Grant | Cash or cash equivalent | $25,000.00 | General |
| Category: BILIARY DEVICES | ||||||
| 04/12/2018 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $15.39 | General |
| 03/13/2018 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXANIBSD (Drug) | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/08/2018 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $13.35 | General |
| Category: HEPATOLOGY GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 831 | 915 | $1.1M | $111,374 |
| 2022 | 25 | 939 | 1,054 | $1.1M | $115,822 |
| 2021 | 23 | 903 | 976 | $949,851 | $106,024 |
| 2020 | 21 | 737 | 802 | $771,942 | $85,057 |
All Medicare Procedures & Services
95 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 148 | 149 | $283,100 | $31,221 | 11.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 78 | 116 | $46,292 | $12,261 | 26.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 52 | 52 | $28,774 | $6,624 | 23.0% |
| 43274 | Insertion of stent into pancreatic or bile duct using a flexible endoscope | Facility | 2023 | 13 | 16 | $48,000 | $6,205 | 12.9% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 67 | 71 | $106,500 | $5,587 | 5.2% |
| 43264 | Removal of stone or debris from bile or pancreatic duct using a flexible endoscope | Facility | 2023 | 20 | 26 | $48,204 | $4,964 | 10.3% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 26 | 26 | $39,000 | $4,872 | 12.5% |
| 43273 | Exam of common bile and/or pancreatic duct using a flexible endoscope | Facility | 2023 | 30 | 40 | $80,640 | $3,968 | 4.9% |
| 45390 | Removal of large bowel tissue using a flexible endoscope | Facility | 2023 | 12 | 12 | $40,800 | $3,510 | 8.6% |
| 43238 | Ultrasound guided needle aspiration or biopsy of esophagus using a flexible endoscope | Facility | 2023 | 19 | 19 | $39,900 | $3,226 | 8.1% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 44 | 45 | $12,375 | $3,156 | 25.5% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 37 | 37 | $35,631 | $3,154 | 8.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 27 | 28 | $10,500 | $2,972 | 28.3% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 31 | 31 | $55,800 | $2,792 | 5.0% |
| 43237 | Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope through mouth | Facility | 2023 | 20 | 21 | $41,979 | $2,766 | 6.6% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 17 | 17 | $25,500 | $2,568 | 10.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 30 | 35 | $10,630 | $2,482 | 23.3% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2023 | 12 | 13 | $37,486 | $1,498 | 4.0% |
| 43262 | Incision of pancreatic outlet using a flexible endoscope | Facility | 2023 | 26 | 26 | $52,000 | $1,299 | 2.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 15 | 15 | $6,005 | $1,177 | 19.6% |
| 91010 | Study of esophagus to assess movement | Office | 2023 | 20 | 20 | $11,000 | $1,089 | 9.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 13 | 16 | $2,873 | $1,072 | 37.3% |
| 74330 | Review by radiologist of image from tube placement into bile and pancreatic duct using an endoscope | Facility | 2023 | 30 | 40 | $8,000 | $939.20 | 11.7% |
| 91037 | Monitoring and recording of esophageal function through nasal tube with electrode | Office | 2023 | 20 | 20 | $11,000 | $825.00 | 7.5% |
| 91010 | Study of esophagus to assess movement | Facility | 2023 | 12 | 12 | $6,600 | $653.52 | 9.9% |
About Dr. Fernando Calmet, M.D
Dr. Fernando Calmet, M.D is a Internal Medicine healthcare provider based in Portland, Maine. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/26/2010. The National Provider Identifier (NPI) number assigned to this provider is 1659690956.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Fernando Calmet, M.D has received a total of $50,905 in payments from pharmaceutical and medical device companies, with $116.64 received in 2024. These payments were reported across 43 transactions from 8 companies. The most common payment nature is "Grant" ($50,000).
As a Medicare-enrolled provider, Calmet has provided services to 3,410 Medicare beneficiaries, totaling 3,747 services with total Medicare billing of $418,277. Data is available for 4 years (2020–2023), covering 95 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Hepatology, Gastroenterology
- Location Portland, ME
- Active Since 05/26/2010
- Last Updated 07/23/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1659690956
Products in Payments
- GENERAL BILIARY DEVICES (Device) $50,000
- XIFAXAN (Drug) $454.34
- STELARA (Biological) $91.44
- SKYRIZI (Biological) $47.69
- Humira (Biological) $34.71
- OCALIVA (Drug) $28.33
- RINVOQ (Biological) $23.69
- ORISE (Device) $23.20
- XIFAXANIBSD (Drug) $15.95
- DIFICID (Drug) $12.17
- REMICADE (Biological) $11.36
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Portland
Nananda Col, Md, MD
Internal Medicine — Payments: $1.1M
Stephen Yau, M.d, M.D
Internal Medicine — Payments: $980,262
Ethan Korngold, Md, MD
Internal Medicine — Payments: $610,759
Dr. Firas Zahr, Md, MD
Internal Medicine — Payments: $543,624
Dr. Martin Moehlen, M.d, M.D
Internal Medicine — Payments: $318,908
Scott Chadderdon, Md, MD
Internal Medicine — Payments: $189,078